Valuation: Grand Pharmaceutical Group Limited

Market Cap 15.51B 1.98B 1.77B 1.64B 1.48B 2.77B 188B 2.82B 19.69B 7.79B 98.4B 7.42B 7.26B 312B P/E 2026 *
8.6x
P/E 2027 * 7.88x
Enterprise Value 15.51B 1.98B 1.77B 1.64B 1.48B 2.77B 188B 2.82B 19.69B 7.79B 98.4B 7.42B 7.26B 312B EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.1x
Free-Float
34.99%
Yield 2026 *
4.74%
Yield 2027 * 5.19%
1 day-0.56%
1 week-3.49%
Current month-10.14%
1 month-6.93%
3 months-14.64%
6 months-32.47%
Current year-43.57%
1 week 4.32
Extreme 4.325
4.73
1 month 4.32
Extreme 4.325
4.96
Current year 4.32
Extreme 4.325
8.18
1 year 4.32
Extreme 4.325
8.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
9/7/26 A Other

Chief Executive Officer

21,500 0.0006%
4/22/26 A Other

Chairman

50,000 0.0014%
4/21/26 A Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-3.49%-45.91%+10.75% 1.99B
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average +0.22%+1.15%+29.03%+64.08% 400.56B
Weighted average by Cap. +0.31%+1.63%+41.36%+81.00%

Financials

2026 *2027 *
Net sales 12.94B 1.65B 1.48B 1.36B 1.24B 2.31B 157B 2.35B 16.42B 6.5B 82.1B 6.19B 6.06B 260B 14.1B 1.8B 1.61B 1.49B 1.35B 2.52B 171B 2.56B 17.89B 7.08B 89.45B 6.75B 6.6B 283B
Net income 1.83B 233M 208M 193M 174M 326M 22.15B 332M 2.32B 917M 11.59B 874M 855M 36.68B 1.99B 254M 227M 210M 190M 356M 24.15B 362M 2.53B 999M 12.63B 953M 932M 39.99B
Net Debt - -
Projected Income Statement - Annual - Grand Pharmaceutical Group Limited
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
26/10/26 HK$4.430 -0.56% 3,182,000
23/10/26 HK$4.455 +1.14% 1,809,000
22/10/26 HK$4.405 -3.72% 5,672,500
21/10/26 HK$4.575 -2.03% 2,235,500
20/10/26 HK$4.670 +1.74% 4,826,500
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Grand Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.430HKD
Average target price
9.527HKD
Spread / Average Target
+115.05%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Grand Pharmaceutical Group Limited